One‐year outcomes of deep brain stimulation in refractory Tourette syndrome

Abstract

AimDeep brain stimulation (DBS) is one option for treating refractory Tourette syndrome (TS); however, it remains unclear which preoperative factors are predictive of DBS outcomes. This study investigated the efficacy of DBS targeting the anteromedial globus pallidus internus and evaluated predisposing factors affecting the outcomes of DBS in a single center in Korea.MethodTwenty patients who had undergone DBS for refractory TS were reviewed retrospectively. Tic symptoms were followed up at 3‐month intervals for up to 1 year after surgery. The Yale Global Tic Severity Scale was used to evaluate preoperative/postoperative tic symptoms. Scores from the Yale‐Brown Obsessive Compulsive Scale, Beck Depression Inventory‐II, and Beck Anxiety Inventory were also evaluated.ResultsPatients with refractory TS achieved improvement in tic symptoms within 1 year after DBS. Initial responders who achieved a 35% reduction in Yale Global Tic Severity Scale total score within the first 3 months after DBS showed larger treatment effects during 1‐year follow‐up. Although no clinical or demographic factors were predictive of initial responses, patients with serious self‐injurious behaviors tended to show delayed responses.ConclusionThis is the first study to our knowledge to report the DBS outcomes of 20 patients with TS in a single center in Asia. Our study supports the efficacy of DBS targeting anteromedial globus pallidus internus in refractory TS with no evident serious adverse events. Initial responses after DBS seem to be a predictor of long‐term outcomes after surgery.